1. Global Cancer Observatory, International Agency for Research on Cancer/World Health Organization. Liver Cancer Fact Sheet 2020. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf.
2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines : Management of hepatocellular carcinoma. J Hepatol 2018;69:182-236.
3. Global Cancer Observatory, International Agency for Research on Cancer/World Health Organization. Portugal Fact Sheet 2020. Available at: https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf.
4. Silva MJ, Simões G, Saraiva R, Calinas F, Nogueira PJ. Epidemiologia do carcinoma hepatocelular em Portugal. Congresso Português de Hepatologia 2021.
5. Harris PS, Hansen RM, Gray ME, Massoud OI, McGuire BM, Shoreibah MG. Hepatocellular carcinoma surveillance : An evidence-based approach. World J Gastroenterol 2019;25:1550-1559.
6. Feldman MF, Friedman LS, Brandt LJ (ed). Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 10th edition; USA, Elsevier Saunders, 2016.
7. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease : An international expert consensus statement. J Hepatol 2020;73:202-209.
8. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
9. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019;16:589-604.
